Publications by authors named "J A Johns"

This study investigates the synergistic effects of incorporating modified zinc oxide-silica (ZnO-SiO) into tire waste (TW) and epoxidized natural rubber (ENR) blends, with a focus on crosslinking dynamics, mechanical reinforcement, and antibacterial activity. The addition of ZnO-SiO significantly enhanced crosslink density, as evidenced by increased torque and accelerated cure rates. An optimal concentration of 10 phr was found to yield the highest performance.

View Article and Find Full Text PDF

Background Appendicectomies are the most frequently performed acute general surgery. The risk of complications depends on several factors, including patient age, American Society of Anesthesiologists (ASA), duration of symptoms, serum inflammatory markers, and the grade of inflammation. Prior research failed to demonstrate a relationship between the rate of complications and the surgeon's level of experience.

View Article and Find Full Text PDF

Mirikizumab is a p19-directed anti-interleukin-23 antibody approved for the treatment of adults with moderate-to-severe ulcerative colitis (UC). Here, we report the first data of mirikizumab pharmacokinetics (PK) and exposure-response (E/R) relationships in pediatric participants (aged 2 to <18 years weighing >10 kg) with moderate-to-severe UC from the phase II, open-label study SHINE-1 (NCT04004611). PK parameters were analyzed using a model developed previously in adults with fixed-exponent allometry for body weight.

View Article and Find Full Text PDF

Objective: This study aimed to increase understanding of the signs and symptoms that lead pregnant people to seek hospital care in the second trimester of pregnancy. In addition, we aimed to describe management and follow up, to record pregnancy outcomes, and to gather information about symptoms and signs related to second trimester pregnancy loss.

Methods: This prospective audit in seven geographically dispersed sites across the UK collected data over two weeks (7th March-20th March 2022 inclusive) on all unscheduled secondary care attendances between 14 and 21 completed weeks' gestation.

View Article and Find Full Text PDF